Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+407K
-
Total reported value, excl. options
-
$1.12B
-
Value change
-
+$14.5M
-
Put/Call ratio
-
0
-
Number of buys
-
70
-
Number of sells
-
-36
-
Price
-
$20.93
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2020
130 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q2 2020.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 107M outstanding shares and own 49.75% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (16.8M shares), BlackRock Inc. (2.98M shares), TANG CAPITAL MANAGEMENT LLC (2.97M shares), PERCEPTIVE ADVISORS LLC (2.19M shares), VANGUARD GROUP INC (1.93M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.71M shares), WELLINGTON MANAGEMENT GROUP LLP (1.69M shares), STATE STREET CORP (1.59M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.55M shares), and Cormorant Asset Management, LP (1.47M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.